We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6951:TSEJEOL Ltd. Analysis

Data as of 2026-03-16 - not real-time

¥6,054.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

JEOL Ltd. is trading just above its 20‑day SMA of 6,399 and well above the 50‑day SMA, indicating short‑term price support, while the 200‑day SMA remains far lower, underscoring a longer‑term bullish bias. The RSI sits at 44, suggesting neutral momentum, but the MACD histogram is deep in negative territory and the signal line is bearish, warning of possible short‑term pull‑back. Volatility over the past 30 days is elevated at roughly 41%, yet the beta of 0.64 points to lower systematic risk relative to the market. Valuation metrics show a trailing P/E of 17.6 versus an industry average of 34.2, and a forward P/E near 11, marking the stock as clearly undervalued. The dividend yield of 1.77% coupled with a modest payout ratio of 33% signals sustainable income.
Fundamentally, revenue has slipped modestly by 2.8% while margins stay healthy (gross ~46%, operating ~20%). Strong cash of ¥38 bn offsets a moderate debt load, delivering a comfortable balance sheet. Forward EPS projections suggest robust earnings growth, and analyst targets imply upside of roughly 13% with a median price of ¥7,300. The combination of attractive valuation, solid cash generation, and a stable dividend makes JEOL a compelling candidate for investors seeking both value and income.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support levels
  • bearish MACD momentum
  • stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant valuation discount to industry peers
  • forward earnings acceleration
  • sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • strong cash position and manageable debt
  • diversified product portfolio across high‑tech sectors
  • ongoing demand for scientific and metrology instruments

Key Metrics & Analysis

Financial Health

Revenue Growth-2.80%
Profit Margin8.54%
P/E Ratio17.6
ROE11.19%
ROA8.27%
Debt/Equity8.06
P/B Ratio2.1
Industry P/E34.2

Technical Analysis

TrendBullish
RSI44.2
Support¥5,776.00
Resistance¥6,993.00
MA 20¥6,399.20
MA 50¥6,056.62
MA 200¥5,032.55
MACDBearish
VolumeStable
Fear & Greed Index79.13

Valuation

Target Price¥6,840.00
Upside/Downside12.98%
GradeUndervalued
TypeValue
Dividend Yield1.77%

Risk Assessment

Beta0.64
Volatility40.90%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.